# APP Deficiency Ameliorates FAD Presenilin 1 F105C and A246E Mutations-induced Mitochondrial Dysfunction in Human Cortical Neurons

**Authors:** Yu-Hsin Yen, Fang Yuan, Daijiao Tang, Jing-Fang Luo, Chen Ming, Phil-Jun Kang, Huanxing Su, Cheong-Meng Chong, Su-Chun Zhang

PMC · DOI: 10.7150/ijbs.120062 · 2026-02-18

## TL;DR

Reducing APP levels helps fix mitochondrial problems caused by FAD-linked PS1 mutations in human brain cells.

## Contribution

The study shows APP deficiency can alleviate PS1 mutation-induced mitochondrial dysfunction in human cortical neurons.

## Key findings

- Mitochondrial dysfunction is a key pathway altered in sporadic AD cortex.
- APP knockout reduces mitochondrial defects and AD-related phenotypes in PS1 mutant neurons.
- Findings highlight APP's role in linking PS1 mutations to mitochondrial dysfunction in AD.

## Abstract

Mitochondrial dysfunction is widely regarded as a central and early feature of Alzheimer's disease (AD) pathology. Prior studies suggest that the accumulation of amyloid precursor protein (APP) within mitochondria contributes to this dysfunction. Mutations in presenilin-1 (PS1), which account for most cases of early-onset familial AD (FAD), have also been shown to impair mitochondrial function. In this study, we investigated how APP influences PS1 mutation-induced mitochondrial dysfunction in human cortical neurons derived from patient induced pluripotent stem cells (iPSCs).

We analyzed transcriptomic and proteomic datasets from postmortem sporadic AD cortex to identify key dysregulated pathways. To functionally interrogate selected mechanisms, we established a panel of CRISPR/Cas9-engineered human iPSC lines, including PS1 mutant lines (PS1+/F105C and PS1+/A246E), an APP knockout derivative (APP-/-_PS1+/F105C), and their isogenic wild-type controls. These iPSCs were differentiated into cortical neurons for functional studies. Following directed differentiation into cortical neurons, biochemical analyses and super-resolution imaging were conducted to evaluate mitochondrial and neuronal phenotypes.

Analyses of sporadic AD cortical transcriptomes and proteomes identified mitochondrial dysfunction as a prominently altered pathway. In agreement, cortical neurons differentiated from FAD PS1 mutant (F105C and A246E) iPSCs displayed mitochondrial defects and AD-related phenotypes, both of which were mitigated by APP knockout.

These findings provide critical insights into the bridging role of APP in FAD PS1 mutant-mediated mitochondrial dysfunction, advancing our understanding of the cellular mechanisms underlying AD.

## Linked entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351], PSEN1 (presenilin 1) [NCBI Gene 5663]
- **Diseases:** Alzheimer's disease (MONDO:0004975), AD (MONDO:0004975)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) [NCBI Gene 4714] {aka ASHI, CI-ASHI, MC1DN32}, CTRL (chymotrypsin like) [NCBI Gene 1506] {aka CTRL1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ATP5MC1 (ATP synthase membrane subunit c locus 1) [NCBI Gene 516] {aka ATP5A, ATP5G, ATP5G1}, PSEN1 (presenilin 1) [NCBI Gene 5663] {aka ACNINV3, AD3, CMD1U, FAD, PS-1, PS1}, TBR1 (T-box brain transcription factor 1) [NCBI Gene 10716] {aka AUTS5, IDDAS, TBR-1, TES-56}, UTRN (utrophin) [NCBI Gene 7402] {aka DMDL, DRP, DRP1}, OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976] {aka BERHS, MGM1, MTDPS14, MTDPS14A, MTDPS14B, NPG}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, MFN1 (mitofusin 1) [NCBI Gene 55669] {aka hfzo1, hfzo2}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, TOMM20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 9804] {aka MAS20, MOM19, TOM20}, RBFOX3 (RNA binding fox-1 homolog 3) [NCBI Gene 146713] {aka FOX-3, FOX3, HRNBP3, NEUN}, FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323] {aka FL, FLG3L, FLT3L, IMD125}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, FIS1 (fission, mitochondrial 1) [NCBI Gene 51024] {aka CGI-135, TTC11}, NFASC (neurofascin) [NCBI Gene 23114] {aka NEDCPMD, NF, NRCAML}, TOMM40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 10452] {aka C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, UQCRC2 (ubiquinol-cytochrome c reductase core protein 2) [NCBI Gene 7385] {aka MC3DN5, QCR2, UQCR2}, NANOG (Nanog homeobox) [NCBI Gene 79923], SDHB (succinate dehydrogenase complex iron sulfur subunit B) [NCBI Gene 6390] {aka CWS2, IP, MC2DN4, PGL4, PPGL4, SDH}
- **Diseases:** TMM (MESH:C566367), neuronal dysfunction and degeneration (MESH:D009410), dementia (MESH:D003704), APP Deficiency (MESH:C000718787), neuronal deficits (MESH:D009461), necrotic (MESH:D009336), cognitive decline (MESH:D003072), memory loss (MESH:D008569), neurofibrillary (MESH:D055956), mitochondrial defects (MESH:C565376), neurodegeneration (MESH:D019636), mitochondria dysfunction (MESH:C564971), Mitochondrial Dysfunction (MESH:D028361), MSBB (MESH:C537181), MCI (MESH:D060825), AD (MESH:D000544)
- **Chemicals:** ATP (MESH:D000255), SB431542 (MESH:C459179), CO2 (MESH:D002245), rotenone (MESH:D012402), tetramethylrhodamine, ethyl ester (MESH:C110932), PFA (MESH:C003043), antimycin A (MESH:D000968), FL (MESH:D005459), SDS (MESH:D012967), poly-ornithine (MESH:C008973), DAPI (MESH:C007293), FCCP (MESH:D002259), oligomycin (MESH:D009840), CloneR (-), acid (MESH:D000143), oxygen (MESH:D010100), penicillin (MESH:D010406), DPBS (MESH:C012939), N2 (MESH:D009584), F12 (MESH:C007782), Triton  X-100 (MESH:D017830), compound E (MESH:D003348), streptomycin (MESH:D013307)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A246E, F105C, M139V, E280A, F10C, A97V, p.Met146Ile, S170F, G substitution at nucleotide 314
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), XF — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_6E64), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), N2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965328/full.md

---
Source: https://tomesphere.com/paper/PMC12965328